Outcome After Treatment of Pulmonary Aspergilloma

Outcome After Surgical Treatment or Bronchial Embolisation in Aspergilloma of the Lung: a Single Center Experience.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01958710

Enrollment

100

Registered

2013-10-09

Start date

2013-10-31

Completion date

2014-06-30

Last updated

2013-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Fungal Diseases

Keywords

Catheterization, Bronchial, Pneumonectomy, Lobectomy, Thoracoplasty

Brief summary

Retrospective analysis of surgery and/or bronchial embolisation for pulmonary aspergilloma.

Detailed description

A retrospective chart analysis, based on the search results from a thoracic surgery database and an interventional radiology database. Outcome analysis of all surgically treated patients for a confirmed invasive aspergilloma. Comparisson with (preoperative) embolisation of the bronchial circulation.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to 89 Years

Healthy volunteers

Inclusion criteria

* Histological proven Aspergilloma of the lung

Exclusion criteria

* Treatment limited to the use of systemic antifungal agents

Design outcomes

Primary

Measure	Time frame	Description
survival after treatment	10 years	estimated 10 yaer survival after treatment for pulmonary aspergilloma

Secondary

Measure	Time frame	Description
post treatment survival	90 days	survival status at 90 days after initiation of treatment

Countries

Belgium

Outcome results